30 Day Psychedelic Pharmacology Podcast - Day 11 Therapeutic Use for Depression

from Cannabinoid and Psychedelic Pharmacology and Drug Development

This podcast episode explores the therapeutic potential of psychedelics for treating depression, comparing them with traditional antidepressants. The discussion covers key mechanisms including 5HT2A receptor interactions, neuroplasticity, and the role of BDNF in brain health. The episode delves into specific psychedelics like MDMA and psilocybin, explaining their effects on brain chemistry and mood regulation. It also addresses important considerations about set and setting, potential risks, and the current state of research in psychedelic therapy.

NOW PLAYING

0:00 20:20

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cannabinoid and Psychedelic Pharmacology and Drug Development?

This episode is 20 minutes long.

When was this Cannabinoid and Psychedelic Pharmacology and Drug Development episode published?

This episode was published on January 30, 2025.

What is this episode about?

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Cannabinoid and Psychedelic Pharmacology and Drug Development episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!